ACDM AI Conference Report

In his opening remarks, Ashley Howard reflects on the first ACDM AI Symposium held in London. The photo features, among others, Oliver Herrmann (CEO, QFINITY) taking part in the major panel discussion of 2022.

Due to the great success of the ACDM AI Conferences over the past three years and the rapid developments in the field of Artificial Intelligence, ACDM once again hosted a two-day AI Conference in June 2025.

The AI Conference offered a diverse program including innovative training sessions, hands-on case studies, engaging presentations, expert panels, and numerous networking opportunities. The aim was to further promote the responsible use of AI technologies in clinical trials. Representatives from pharmaceutical companies, CROs, and technology providers gathered in Frankfurt to discuss current developments and future perspectives in Artificial Intelligence.

QFINITY once again supported the event through Marcus Schwabedissen, COO and permanent member of the Steering Committee since 2022, who contributed to the planning, preparation, and execution of the event. He chaired the track focused on validation, compliance, and ethics in the context of AI.

Due to the positive feedback, ACDM is looking forward to more successful AI Symposia in the future.

For more information about ACDM events, please click here.